Clinical Trial Update: Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compares hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in patients with unresectable li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: COMPLETED